| Dr Brian Dennis Karriker, DDS | |
|
484 River Hwy Ste E, Mooresville, NC 28117-6953 | |
| (704) 662-3399 | |
| (704) 662-0933 |
| Full Name | Dr Brian Dennis Karriker |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 484 River Hwy Ste E, Mooresville, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073813010 | NPI | - | NPPES |
| 9031 | Other | NC STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 9031 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Dennis Karriker, DDS 5014 Mill Creek Rd, Clover, SC 29710-8009 Ph: (336) 403-9136 | Dr Brian Dennis Karriker, DDS 484 River Hwy Ste E, Mooresville, NC 28117-6953 Ph: (704) 662-3399 |
News Archive
A team of researchers led by McMaster University's Charu Kaushic has revealed for the first time how estradiol, a female sex hormone present during the menstrual cycle and found in oral contraceptives, may work to protect women against sexually transmitted viral infections.
BioMarin Pharmaceutical Inc. has announced that AnGes MG, Inc. (AnGes), BioMarin's marketing and distribution partner in Japan, has received approval for its Marketing Application for Naglazyme(R) (galsulfase) from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with Mucopolysaccharidosis VI ( MPS VI).
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, today commented on a Special Notice published by the US Department of Health and Human Services (DHHS), Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA) on December 29, 2009.
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
› Verified 9 days ago
Dr. Charles Waitsel Roberts Iv, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 142 Professional Park Dr, Suite 200, Mooresville, NC 28117 Phone: 704-664-5437 Fax: 704-663-7912 | |
Dr. Rita Bhat, DMD Dentist Medicare: Medicare Enrolled Practice Location: 134 Professional Park Dr Ste 100, Mooresville, NC 28117 Phone: 704-799-0377 Fax: 704-799-0378 | |
Dr. Kellie Paxton, D.M.D., M.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 202 Williamson Rd, Suite 202, Mooresville, NC 28117 Phone: 704-799-0110 | |
Dr. Diane Edith Haberl, DDS PA Dentist Medicare: Medicare Enrolled Practice Location: 747 Brawley School Rd, Mooresville, NC 28117 Phone: 704-663-3001 Fax: 704-663-6954 | |
Dr. Shawn Buffington, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 747 Brawley School Rd, Mooresville, NC 28117 Phone: 704-663-3001 | |
Laura L. Grier, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 128 E Plaza Dr, Suite 1 & 2, Mooresville, NC 28115 Phone: 704-799-2703 |